Pilar Nava-Parada: all publications

• Publications

  • Nava-Parada P, Emens L. GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers. Current opinion in molecular therapeutics 9 (5) , 490-7 (2007) PubMed ID:(17932813)

  • Carbó R, Nava P, Guarner V. Effects of polarizing solution on glucose uptake of rat oxygenated or hypoxic ventricular myocytes. Clinical and experimental pharmacology & physiology 30 (1-2) , 64-71 PubMed ID:(12542456)

  • Nava P, Carbó R, Cumming E, Guarner V. [The intracellular mechanisms of calcium and insulin in the association of arterial hypertension with diabetes] Archivos del Instituto de Cardiología de México 69 (5) , 469-77 PubMed ID:(10640211)

  • Nava P, Carbó R, Guarner V. 17 beta-estradiol modulates effects of insulin-induced changes in vascular contractility. Archivos de cardiología de México 73 (4) , 253-60 PubMed ID:(14959449)

  • Nava P, Carbó R, Guarner V. Coronary and femoral arterial contraction with high glucose, insulin, and glucose-insulin-potassium solution: effects of hypoxia. Heart and vessels 16 (2) , 57-63 PubMed ID:(11833843)

  • Nava P, Collados M, Massó F, Guarner V. Endothelin mediation of insulin and glucose-induced changes in vascular contractility. Hypertension 30 (4) , 825-9 PubMed ID:(9336379 )

  • Nava P, Guarner V, Posadas R, Pérez I, Baños G. Insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats. The American journal of physiology 277 (1 Pt 2) , H399-404 PubMed ID:(10409220)

  • Nava-Parada P, Forni G, Knutson K, Pease L, Celis E. Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors. Cancer research 67 (3) , 1326-34 PubMed ID:(17283170)